| Multiple stent fractures at the site of coronary artery bypass insertion. | |
| | |
MedLine Citation:
|
PMID: 19089946 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Drug eluting stents have led to a substantial reduction of in-stent restenosis. Stent fracture (SF) is an important cause for the cases of restenosis which still occur. Sites of increased vessel movement, long stents, and overlapping stents have been observed to be more prone to fracture. We report the case of a patient with multiple drug eluting SFs at the site of coronary artery bypass insertion. The decision to implant stents at the site of bypass insertion should be made carefully. SF should be considered when gaps between previously implanted stents are observed. |
| | |
Authors:
|
Holger Hetterich; Johannes Rieber |
Related Documents
:
|
20518006 - Angiographic patency and clinical outcome after balloon-angioplasty for extensive infra... 20506126 - First nine-month complete invasive assessment (angiography, ivus, and oct) of the novel... 18258316 - Fracture of a sirolimus-eluting stent with migration. 16336426 - Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era. 15716626 - Spontaneous intracerebral hematoma from transient occult carotid-cavernous fistula: a c... 22537236 - Incremental value of live/real time three-dimensional transesophageal echocardiography ... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Volume: 73 ISSN: 1522-726X ISO Abbreviation: Catheter Cardiovasc Interv Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2008-12-24 Completed Date: 2009-02-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100884139 Medline TA: Catheter Cardiovasc Interv Country: United States |
Other Details:
|
Languages: eng Pagination: 84-7 Citation Subset: IM |
Copyright Information:
|
(c) 2008 Wiley-Liss, Inc. |
Affiliation:
|
Department of Cardiology, Medizinische Poliklinik, Ludwig-Maximilians University, Munich, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary
/
adverse effects,
instrumentation* Cardiovascular Agents / administration & dosage Coronary Angiography Coronary Artery Bypass* Coronary Restenosis / etiology, radiography, therapy* Coronary Stenosis / radiography, surgery* Drug-Eluting Stents* Humans Male Middle Aged Prosthesis Design Prosthesis Failure* Risk Factors Sirolimus / administration & dosage Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents; 53123-88-9/Sirolimus |
| Comments/Corrections | |
Comment In:
|
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):88-9
[PMID:
19089948
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High pressure reveals structural determinants for globin hexacoordination: neuroglobin and myoglobin...
Next Document: Natural history of the E1-like superfamily: implication for adenylation, sulfur transfer, and ubiqui...